摘要
难治性气胸是常见的临床急诊危重症,是由于肺组织与胸膜腔形成的瘘不易闭合所致,严重影响患者的生活质量,给患者带来了巨大的经济负担。因此,难治性气胸的临床治疗成为解决上述问题的关键。近年来,自体血封堵作为一种能有效治疗难治性气胸的技术,在临床上被广泛应用,为我们临床诊治及难治性气胸提供了一条重要途径。本文就自体血封堵技术在难治性气胸中的研究现状及前景进行综述。
Refractory pneumothorax is a common critical disease in clinical emergency. It is caused by the difficult closure of the fistula formed between the lung tissue and the pleural cavity, which seriously affects the quality of life of patients and brings huge economic burden to patients. Therefore, the clinical treatment of refractory pneumothorax has become the key to solve the above problems. In recent years, as an effective technique for the treatment of refractory pneumothorax, autologous blood occlusion has been widely used in clinical practice, providing an important way for the clinical diagnosis and treatment of refractory pneumothorax. This article reviews the research status and prospect of autogenous blood occlusion in refractory pneumothorax.
出处
《临床医学进展》
2021年第5期2172-2176,共5页
Advances in Clinical Medicine
